We are pleased to announce that CUROGEN has received its fifth national grant from the Korea Drug Development Fund (KDDF) under the "Establishment of New Drug R&D Ecosystem” category.

The project, supported by KDDF, is designed to strengthen Korea’s pharmaceutical capabilities by fostering a comprehensive and collaborative ecosystem for new drug research and development. Through this project, KDDF aims to accelerate innovation, bridge gaps between research institutions and the industry, and enhance the global competitiveness of Korea’s drug development sector.

This project will be carried out for two years, with total funding of 2 billion KRW. This recognition reflects CUROGEN's strong capabilities and commitment to advancing cutting-edge drug development initiatives.

We look forward to contributing to the success of this important national effort and making a meaningful impact in the biomedical field.